GlycoMimetics Inc (GLYC)
1.71
-0.14
(-7.82%)
USD |
NASDAQ |
Apr 25, 16:00
1.70
-0.01
(-0.58%)
After-Hours: 20:00
GlycoMimetics Price to Book Value: 2.869 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 25, 2024 | 2.869 |
April 24, 2024 | 3.112 |
April 23, 2024 | 3.079 |
April 22, 2024 | 3.02 |
April 19, 2024 | 3.230 |
April 18, 2024 | 3.624 |
April 17, 2024 | 3.825 |
April 16, 2024 | 3.607 |
April 15, 2024 | 3.783 |
April 12, 2024 | 4.027 |
April 11, 2024 | 4.203 |
April 10, 2024 | 4.110 |
April 09, 2024 | 4.496 |
April 08, 2024 | 4.345 |
April 05, 2024 | 4.614 |
April 04, 2024 | 4.547 |
April 03, 2024 | 4.639 |
April 02, 2024 | 4.966 |
April 01, 2024 | 5.100 |
March 28, 2024 | 5.033 |
March 27, 2024 | 5.335 |
March 26, 2024 | 4.782 |
March 25, 2024 | 4.731 |
March 22, 2024 | 4.916 |
March 21, 2024 | 4.832 |
Date | Value |
---|---|
March 20, 2024 | 5.117 |
March 19, 2024 | 4.916 |
March 18, 2024 | 4.698 |
March 15, 2024 | 4.295 |
March 14, 2024 | 4.375 |
March 13, 2024 | 4.274 |
March 12, 2024 | 4.392 |
March 11, 2024 | 4.291 |
March 08, 2024 | 4.576 |
March 07, 2024 | 4.694 |
March 06, 2024 | 4.861 |
March 05, 2024 | 4.861 |
March 04, 2024 | 5.096 |
March 01, 2024 | 5.046 |
February 29, 2024 | 4.844 |
February 28, 2024 | 4.811 |
February 27, 2024 | 5.062 |
February 26, 2024 | 5.129 |
February 23, 2024 | 4.861 |
February 22, 2024 | 4.912 |
February 21, 2024 | 5.012 |
February 20, 2024 | 5.582 |
February 16, 2024 | 5.398 |
February 15, 2024 | 5.180 |
February 14, 2024 | 5.163 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4159
Minimum
Jun 16 2022
5.850
Maximum
Jan 23 2024
1.594
Average
1.228
Median
Aug 11 2020
Price to Book Value Benchmarks
Altimmune Inc | 2.630 |
Cellectar Biosciences Inc | -- |
PDS Biotechnology Corp | 4.576 |
Syros Pharmaceuticals Inc | 8.097 |
Precision BioSciences Inc | 3.564 |
Price to Book Value Related Metrics
Price | 1.71 |
Earnings Yield | -33.92% |
Market Cap | 110.21M |